Literature DB >> 8383380

Apparent normobasemia as a negative prognostic sign immediately after hepatectomy.

Y Wada1, K Mori, M Sugano, T Fujii, Y Shimahara, Y Yamaoka, K Ozawa.   

Abstract

The acid-base balance from the postoperative day (POD) 1 to POD 3 after cirrhotic liver resection was investigated in relation to operative outcome by conducting a retrospective study on the changes in arterial ketone body ratio (AKBR), which reflects the hepatic mitochondrial redox state, and arterial blood gas analysis. Patients were grouped according to their outcome: hospital death (HD) and or good outcome, the latter group acting as controls (CTR). Metabolic alkalosis developed in a significant number of the CTR patients (p < 0.01), who had high AKBR values. By contrast, metabolic alkalosis did not develop in the HD group, with significantly lower AKBR (p < 0.001), and there was almost normobasemia. There were no significant differences in the need for mechanical respiratory assistance, the amounts of fresh frozen plasma administered, and renal function test results between the two groups on each of 3 postoperative days. These data indicated that the absence of metabolic alkalosis during the early postoperative days reflects disruption of energy metabolism in the remnant liver, and that the apparent normobasemia is a significant indicator of poor prognosis after cirrhotic liver resection.

Entities:  

Mesh:

Year:  1993        PMID: 8383380     DOI: 10.1007/bf01655722

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

1.  Metabolic alkalosis after massive blood transfusion. Correction by hemodialysis.

Authors:  C G Barcenas; T J Fuller; J P Knochel
Journal:  JAMA       Date:  1976-08-23       Impact factor: 56.272

2.  Regulation of pyruvate dehydrogenase kinase and phosphatase by acetyl-CoA/CoA and NADH/NAD ratios.

Authors:  F H Pettit; J W Pelley; L J Reed
Journal:  Biochem Biophys Res Commun       Date:  1975-07-22       Impact factor: 3.575

3.  Prognostic implications of postoperative suppression of arterial ketone body ratio: time factor involved in the suppression of hepatic mitochondrial oxidation-reduction state.

Authors:  Y Yamamoto; K Ozawa; R Okamoto; T Kiuchi; A Maki; H Lin; K Mori; Y Shimahara; K Kumada; Y Yamaoka
Journal:  Surgery       Date:  1990-03       Impact factor: 3.982

4.  A simple and sensitive assay for blood ketone bodies using highly purified 3-hydroxybutyrate dehydrogenase.

Authors:  S Uno; S Ito; M Kurono; Y Yamaoka; Y Kamiyama; K Ozawa
Journal:  Clin Chim Acta       Date:  1987-09-30       Impact factor: 3.786

5.  Severe alkalosis in critically ill surgical patients.

Authors:  R F Wilson; D Gibson; A K Percinel; M A Ali; G Baker; L P LeBlanc; C Lucas
Journal:  Arch Surg       Date:  1972-08

6.  Development of metabolic alkalosis after massive transfusion during orthotopic liver transplantation.

Authors:  D F Driscoll; B R Bistrian; R L Jenkins; S Randall; W H Dzik; B Gerson; G L Blackburn
Journal:  Crit Care Med       Date:  1987-10       Impact factor: 7.598

7.  The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation.

Authors:  K Asonuma; S Takaya; R Selby; R Okamoto; Y Yamamoto; T Yokoyama; S Todo; K Ozawa; T E Starzl
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

8.  Reduced arterial ketone body ratio during laparotomy: an evaluation of operative stress through the changes in hepatic mitochondrial redox potential.

Authors:  T Kiuchi; Y Shimahara; S Wakashiro; Y Tokunaga; N Ozaki; T Takayasu; K Mori; N Kobayashi; Y Yamaoka; K Ozawa
Journal:  J Lab Clin Med       Date:  1990-04

Review 9.  Liver transplantation.

Authors:  R L Jenkins; P N Benotti; A A Bothe; R L Rossi
Journal:  Surg Clin North Am       Date:  1985-02       Impact factor: 2.741

10.  Changes in blood ketone body ratio: their significance after major hepatic resection.

Authors:  M Ukikusa; K Ozawa; Y Shimahara; M Asano; T Nakatani; T Tobe
Journal:  Arch Surg       Date:  1981-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.